glp-1 obesity drug news today sep 30 2025 weight loss drugs leave users low on key nutrients, study finds ISPOR 2025: Exploring reasons for
Description
Primary care physicians often make decisions regarding the initiation of basal insulin in T2D, as they work closely with patients and are well placed to discuss and manage the transition to basal insulin therapy
Jardiance is the brand name for empagliflozin, an oral SGLT2 inhibitor tablet used in adult cardiometabolic care
The study highlights that after stopping GLP-1 medications, many patients resume treatment or try alternatives, influencing weight management strategies.
Learn about the benefits of GLP-1 weight loss medications and how they work to support weight management effectively.
